Skip to content
Menu

BioHarvest Sciences Sees FY2026 Sales $42.000M-$48.000M vs $48.432M Est

Benzinga Newsdesk 7 months ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BioHarvest Sciences (NASDAQ:BHST) sees FY2026 sales of $42.000 million-$48.000 million vs $48.432 million analyst estimate.

BioHarvest Sciences (NASDAQ:BHST) sees FY2026 sales of $42.000 million-$48.000 million vs $48.432 million analyst estimate.

Read at benzinga.com